Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

4D Molecular Therapeutics Inc (FDMT)

4D Molecular Therapeutics Inc (FDMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

4D Molecular Therapeutics Inc 5858 HORTON STREET #455 EMERYVILLE CA 94608 USA

www.4dmoleculartherapeutics.com P: 510-505-2680

Description:

4D Molecular Therapeutics Inc. is a clinical-stage gene therapy company which develops product candidates using its targeted and evolved adeno-associated viruses vectors. It offers a portfolio of gene therapy product candidates focusing on the ophthalmology, cardiology and pulmonology therapeutic areas. 4D Molecular Therapeutics Inc. is based in Emeryville, California.

Key Statistics

Overview:

Market Capitalization, $K 1,331,352
Enterprise Value, $K 1,082,242
Shares Outstanding, K 51,703
Annual Sales, $ 20,720 K
Annual Net Income, $ -100,840 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -32,400 K
EBIT, $ -120,900 K
EBITDA, $ -117,940 K
60-Month Beta 2.94
% of Insider Shareholders 7.30%
% of Institutional Shareholders 99.27%
Float, K 47,929
% Float 92.70%
Short Volume Ratio 0.28

Growth:

1-Year Return 43.55%
3-Year Return -2.50%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.66 on 05/09/24
Latest Earnings Date 05/08/24
Earnings Per Share ttm -2.44
EPS Growth vs. Prev Qtr 14.29%
EPS Growth vs. Prev Year 25.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FDMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.75%
Return-on-Assets % -24.84%
Profit Margin % -486.68%
Debt/Equity 0.00
Price/Sales 63.80
Price/Cash Flow N/A
Price/Book 2.19
Book Value/Share 11.74
Interest Coverage -1.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar